Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria
Angelo Castello, Massimo Castellani, Luigia Florimonte, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1740-1740
Open Access | Times Cited: 22

Showing 22 citing articles:

Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 498-512
Closed Access | Times Cited: 62
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review
Luca Urso, Luigi Manco, Angelo Castello, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13409-13409
Open Access | Times Cited: 40
Tumor Microenvironment, Radiology, and Artificial Intelligence: Should We Consider Tumor Periphery?
Afshin Mohammadi, Mohammad Mirza‐Aghazadeh‐Attari, Fariborz Faeghi, et al.
Journal of Ultrasound in Medicine (2022) Vol. 41, Iss. 12, pp. 3079-3090
Closed Access | Times Cited: 24
Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors
Fariba Tohidinezhad, Dennis Bontempi, Zhen Zhang, et al.
European Journal of Cancer (2023) Vol. 183, pp. 142-151
Open Access | Times Cited: 15
PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer
Jeremy McGale, Sakshi Khurana, Alice Huang, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 4882-4882
Open Access | Times Cited: 14
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection
Ilaria Ferrigno, Laura Verzellesi, Marta Ottone, et al.
Inflammation Research (2024) Vol. 73, Iss. 4, pp. 515-530
Closed Access | Times Cited: 5
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature
Laura Evangelista, Francesco Fiz, Riccardo Laudicella, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3258-3258
Open Access | Times Cited: 12
Robust vs. Non-robust radiomic features: the quest for optimal machine learning models using phantom and clinical studies
Seyyed Ali Hosseini, Ghasem Hajianfar, Brandon Hall, et al.
Cancer Imaging (2025) Vol. 25, Iss. 1
Open Access
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer
Luca Urso, Laura Evangelista, Pierpaolo Alongi, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5869-5869
Open Access | Times Cited: 17
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study
Marion Tonneau, Kim Phan, Venkata Manem, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Current role and future prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in Management of Breast Cancer
N. Robson, Dinesh Thekkinkattil
(2024)
Open Access | Times Cited: 3
Clinical Applications of Radiomics and Deep Learning in Breast and Lung cancer: a Narrative Literature Review on Current Evidence and Future Perspectives
Alessandra Ferro, Michele Bottosso, Maria Vittoria Dieci, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104479-104479
Open Access | Times Cited: 3
Current Role and Future Prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in the Management of Breast Cancer
N. Robson, Dinesh Thekkinkattil
Medicina (2024) Vol. 60, Iss. 2, pp. 321-321
Open Access | Times Cited: 2
CT radiomics-based biomarkers can predict response to immunotherapy in hepatocellular carcinoma
Liang Qi, Yahui Zhu, Jinxin Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
Luca Urso, Federica Lancia, Naima Ortolan, et al.
Clinical and Translational Imaging (2022) Vol. 10, Iss. 6, pp. 687-695
Open Access | Times Cited: 10
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review
Luca Urso, Elena Bonatto, Alberto Nieri, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2184-2184
Open Access | Times Cited: 4
Pet Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature
Laura Evangelista, Francesco Fiz, Riccardo Laudicella, et al.
(2023)
Open Access | Times Cited: 4
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake
Alberto Nieri, Luigi Manco, Matteo Bauckneht, et al.
Expert Review of Medical Devices (2023) Vol. 20, Iss. 12, pp. 1183-1191
Closed Access | Times Cited: 4
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art
Luigi Manco, Domenico Albano, Luca Urso, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7669-7669
Open Access | Times Cited: 2
The radiological appearances of lung cancer treated with immunotherapy
Gianluca Milanese, Giulia Mazzaschi, Roberta Eufrasia Ledda, et al.
British Journal of Radiology (2022) Vol. 96, Iss. 1144
Open Access | Times Cited: 2
Imaging Correlates of Immune Checkpoint Inhibitors in Cancer Management
Hanie Karimi, Soha Mohammadi, Parya Valizadeh, et al.
(2023), pp. 1-30
Closed Access
Meditating on Cancer Management at the Time of Immunotherapy
Egesta Lopci
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3025-3025
Open Access
Page 1

Scroll to top